Nalbuphine Hydrochloride Injection
Product Images NDC 0404-9767

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Nalbuphine Hydrochloride (NDC 0404-9767). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula1.jpg (Formula1)

Formula1.jpg (Formula1)
Chemical structure of nalbuphine hydrochloride showing multiple fused rings, hydroxyl groups, and an amine group attached to a cyclobutylmethyl substituent, accompanied by a hydrochloride (HCl) group.*
FDA Label Image

Label1.jpg (Label1)

Label1.jpg (Label1)
Label for Nalbuphine Hydrochloride injection, 10 mg/mL strength in a 10 mL multiple-dose vial. Intended for intramuscular, subcutaneous, or intravenous use. Includes storage instructions to keep at controlled room temperature and protect from excessive light. Label shows NDC 0404-9767-10 and is packaged by Henry Schein, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.